Kampala, Uganda | ISAAC KHISA | Drug manufacturing firm, Cipla Quality Chemical Industries Limited, hopes to raise at least Shs168.56bn through an Initial Public Offer that opened on August 14-24. The firm that is 62.3% owned by India’s Cipla, is offering 657.17million shares at a cost of Shs 256.5 per share. …
Read More »
Analysts anticipate some buzz on market that last had listing in 2012 Kampala, Uganda | JULIUS BUSINGE | Uganda’s Securities Exchange market is set to experience some new buzz again as the long awaited drug maker, Cipla Quality Chemical Industries Ltd (CiplaQCIL), makes an Initial Public Offering this month. The company …
Read More »
Ugandan bourse managers say pharmaceutical firm’s latest plans no different from past claims The Kampala-based pharmaceutical firm Cipla Quality Chemical Industries Ltd, often called just Quality Chemicals Ltd, has once again signaled intention to offer shares to the public in an Initial Public Offer (IPO). The subsidiary of Indian drugs …
Read More »
The High Court in Kampala on Wednesday summoned the Attorney General of Government and National Medical Stores (NMS) to respond to claims that it has continuously withdrawn money from the consolidated fund to purchase imported anti-retroviral and anti-malarial drugs from a local manufacturer disguised as locally made. Documents presented to …
Read More »
NMS, Cipla: Fight over pricing could lead to higher costs for patients and the government “NO ARVs means death.” That shocking but true fact was stated by Joshua Wamboga, the head of the Uganda Network of AIDS Service Organisations (UNASO) in January when Uganda was reeling from a major stock-out …
Read More »
The Independent Uganda: You get the Truth we Pay the Price